Charles Weijer

Biographic Data

ID5396017
NAMECharles Weijer
GIVEN NAMESCharles
FAMILY NAMEWeijer
SIGNATUREWEIJER C
AFFILIATIONSWestern University
ORCID0000-0002-5510-1074
VERIFIEDYes
TOTAL WORKS26
TOTAL CITATIONS0
AUTHOR COUNT26
EDITOR COUNT0
FIRST PUBLICATION YEAR1992
LATEST PUBLICATION YEAR2026
H-INDEX0

  • The ethical permissibility of financial incentives

    Open AccessPepijn Al, Jamie Brehaut et al.ARTICLEMedicine Health Care and Philosophy2026

    Randomized controlled trials are central to progress in medicine, but trialists commonly struggle to recruit the required number of participants. Offering financial incentives is one proposed solution, but financial incentives may be problematic when they become irresistible and, thus, undermine the autonomy of potential participants. While some have dismissed this worry about undue inducement and argued that we should be paying participants more…

  • Navigating the consent river

    Open AccessCory E Goldstein, Monica Taljaard et al.ARTICLEJournal of Medical Ethics2025

    The robust design and conduct of pragmatic cluster randomised trials may be in tension with the ethical requirement to obtain written informed consent from prospective research participants. In our experience, researchers tend to focus on whether a waiver of consent is appropriate for their studies. However, pragmatic cluster randomised trials raise other important questions that have direct implications for determining when an alteration or waiv…

  • Covid-19 human challenge trials and randomized controlled trials

    Open AccessCharles WeijerARTICLEResearch Ethics2024

    The COVID-19 pandemic touched off an unprecedented search for vaccines and treatments. Without question, the development of vaccines to prevent COVID-19 was an enormous scientific accomplishment. Further, the RECOVERY and Solidarity trials identified effective treatments for COVID-19. But all was not success. The urgent need for COVID-19 prevention and treatment fueled an embrace of risks—to research participants and to the reliability of the sci…

  • Ethics of non-therapeutic research on imminently dying patients in the intensive care unit

    Open AccessNicholas Murphy, Nicholas B Murphy et al.ARTICLEJournal of Medical Ethics2023

    Non-therapeutic research with imminently dying patients in intensive care presents complex ethical issues. The vulnerabilities of the imminently dying, together with societal disquiet around death and dying, contribute to an intuition that such research is beyond the legitimate scope of scientific inquiry. Yet excluding imminently dying patients from research hinders the advancement of medical science to the detriment of future patients. Building…

  • Informed consent in pragmatic trials

    Jennifer Zhe Zhang, Stuart G Nicholl et al.ARTICLEJournal of Medical Ethics2023

    OBJECTIVES: To describe reporting of informed consent in pragmatic trials, justifications for waivers of consent and reporting of alternative approaches to standard written consent. To identify factors associated with (1) not reporting and (2) not obtaining consent. METHODS: Survey of primary trial reports, published 2014-2019, identified using an electronic search filter for pragmatic trials implemented in MEDLINE, and registered in ClinicalTria…

  • Family experiences with non-therapeutic research on dying patients in the intensive care unit

    Amanda Van Beinum, Nicholas Murphy et al.ARTICLEJournal of Medical Ethics2022

    Experiences of substitute decision-makers with requests for consent to non-therapeutic research participation during the dying process, including to what degree such requests are perceived as burdensome, have not been well described. In this study, we explored the lived experiences of family members who consented to non-therapeutic research participation on behalf of an imminently dying patient. We interviewed 33 family members involved in surrog…

  • Research bystanders, justice, and the state

    Open AccessNicholas Murphy, Nicholas B Murphy et al.ARTICLEBioethics2022

    Research participants are afforded protections to ensure their rights and welfare are not unduly jeopardized by research activities. Yet people who do not meet the criteria for research participant status may likewise be impacted by research activities, and ethicists argue that protections should be afforded these “research bystanders.” The standard rationale for extending protections to research bystanders contends that they are sufficiently lik…

  • Towards the assessment of quality of life in patients with disorders of consciousness

    Open AccessJasmine Tung, Kathy N Speechley et al.ARTICLEQuality of Life Research2019

  • Cluster Randomized Trials, Ethical Implications of

    Open AccessMonica Taljaard, Charles Weijer et al.CHAPTERInternational Encyclopedia of the…2015

  • Heads or Tails

    Open AccessCharles WeijerARTICLEThe AMA Journal of Ethic2004

    Case Upon inspecting his schedule for the day, psychiatrist David Kimball was surprised to learn that his first patient of the morning was Geoffrey Allen. Geoff had been in for an appointment less than 2 weeks ago to discuss his response to a monoamine oxidase inhibitor (MAOI) as treatment for chronic depression. At the time, it seemed as though the medication was working, a relief for both Geoff and Dr. Kimball after several years of searching f…

  • Informing Study Participants of Research Results

    Conrad V Fernandez, Eric Kodish et al.ARTICLEIRB Ethics and Human Research2003

  • Trial by Error

    Charles Weijer, Baruch A BrodyARTICLEThe Hastings Center Report2001

  • The Ethics Wars Disputes over International Research

    Charles Weijer, James A AndersonARTICLEThe Hastings Center Report2001

    The effort to revise the Declaration of Helsinki and the CIOMS Guidelines has sparked a sometimes vitriolic debate centering on the use of placebo controls

  • Moral Solutions in Assessing Research Risk

    Paul B Miller, Charles WeijerARTICLEIRB Ethics and Human Research2000

  • Thinking Clearly about Research Risk

    Charles WeijerARTICLEIRB Ethics and Human Research1999

    ethics as exposure of muddled and wrong-headed concepts, to clear the way for a healthy growth of ideas.l In his twenty-year career in bioethics, he not only cleared the way but also filled the gap in a wide variety of areas in bioethics, including informed consent, substitute decision making, competency, obligations of health professionals, research ethics, and Judaism and bioethics.2 Perhaps best known among these many contributions is Freedman…

  • Structuring the Review of Human Genetics Protocols Part-III

    Kathleen Cranley Glass, Charles Weijer et al.ARTICLEIRB Ethics and Human Research1999

    Kathleen Cranley Glass, Charles Weijer, Denis Cournoyer, Trudo Lemmens, Reberta M. Palmour, Stanley H. Shapiro, Benjamin Freedman, Structuring the Review of Human Genetics Protocols Part-III: Gene Therapy Studies, IRB: Ethics & Human Research, Vol. 21, No. 2 (Mar. - Apr., 1999), pp. 1-9

  • The IRB's Role in Assessing the Generalizability of Non-NIH-Funded Clinical Trials

    Charles WeijerARTICLEIRB Ethics and Human Research1998

  • Monitoring Informed Consent in an Oncology Study Posing Serious Risk to Subjects

    Myrian Skrutkowski, Charles Weijer et al.ARTICLEIRB Ethics and Human Research1998

    Myrian Skrutkowski, Charles Weijer, Stan Shapiro, Abraham Fuks, Adrian Langleben, Benjamin Freedman, Monitoring Informed Consent in an Oncology Study Posing Serious Risk to Subjects, IRB: Ethics & Human Research, Vol. 20, No. 6 (Nov. - Dec., 1998), pp. 1-6

  • Structuring the Review of Human Genetics Protocols Part II

    Kathleen Cranley Glass, Charles Weijer et al.ARTICLEIRB Ethics and Human Research1997

    Kathleen Cranley Glass, Charles Weijer, Trudo Lemmens, Roberta M. Palmour, Stanley H. Shapiro, Structuring the Review of Human Genetics Protocols Part II: Diagnostic and Screening Studies, IRB: Ethics & Human Research, Vol. 19, No. 3/4 (May - Aug., 1997), pp. 1-11+13

  • Notes on Recent Publications

    Open AccessCharles WeijerARTICLEReligious Studies Review1996

  • Structuring the Review of Human Genetics Protocols

    Kathleen Cranley Glass, Charles Weijer et al.ARTICLEIRB Ethics and Human Research1996

    Kathleen Cranley Glass, Charles Weijer, Roberta M. Palmour, Stanley H. Shapiro, Trudo M. Lemmens, Karen Lebacqz, Structuring the Review of Human Genetics Protocols: Gene Localization and Identification Studies, IRB: Ethics & Human Research, Vol. 18, No. 4 (Jul. - Aug., 1996), pp. 1-9

  • Notes on Recent Publications

    Open AccessCharles WeijerARTICLEReligious Studies Review1995

  • Momento mori

    Anthony Serafini, Charles Weijer et al.ARTICLEThe Hastings Center Report1994

  • Notes on Recent Publications

    Open AccessCharles WeijerARTICLEReligious Studies Review1994

  • In Loco Parentis Minimal Risk as an Ethical Threshold for Research upon Children

    Benjamin Freedman, Abraham Fuks et al.ARTICLEThe Hastings Center Report1993

    Benjamin Freedman, Abraham Fuks, Charles Weijer, In Loco Parentis Minimal Risk as an Ethical Threshold for Research upon Children, The Hastings Center Report, Vol. 23, No. 2 (Mar. - Apr., 1993), pp. 13-19